GlobeNewsWire
04 May 2026, 12:47 UTC · 19w ago
Verdict
Headline takes no side. We score GYRE +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company closed a strategic acquisition of Cullgen and reported positive clinical and regulatory progress for its drug candidates.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1d ago
−3.2%
Price is moving against the score
$7.55 vs $7.80 close before publication (May 1) · not market-adjusted
GYRE chart →
